Jupiter Topco LLC Buys Shares of 4,254,267 The Cooper Companies, Inc. $COO

Jupiter Topco LLC bought a new stake in shares of The Cooper Companies, Inc. (NASDAQ:COO) in the 2nd quarter, Holdings Channel reports. The firm bought 4,254,267 shares of the medical device company’s stock, valued at approximately $305,074,000.

Other hedge funds have also recently made changes to their positions in the company. Avalon Trust Co bought a new position in Cooper Companies during the 2nd quarter valued at approximately $25,000. Root Financial Partners LLC boosted its holdings in Cooper Companies by 104.5% in the fourth quarter. Root Financial Partners LLC now owns 317 shares of the medical device company’s stock worth $26,000 after acquiring an additional 162 shares in the last quarter. SJS Investment Consulting Inc. grew its stake in shares of Cooper Companies by 107.5% in the first quarter. SJS Investment Consulting Inc. now owns 361 shares of the medical device company’s stock worth $26,000 after acquiring an additional 187 shares during the last quarter. Elevation Wealth Partners LLC grew its stake in shares of Cooper Companies by 1,136.4% in the second quarter. Elevation Wealth Partners LLC now owns 408 shares of the medical device company’s stock worth $29,000 after acquiring an additional 375 shares during the last quarter. Finally, J.Safra Asset Management Corp bought a new position in shares of Cooper Companies during the second quarter valued at $32,000. 24.39% of the stock is owned by institutional investors.

Cooper Companies Trading Down 3.6%

Shares of NASDAQ:COO opened at $73.04 on Wednesday. The company has a market cap of $14.24 billion, a P/E ratio of 61.90, a PEG ratio of 1.98 and a beta of 0.83. The company has a debt-to-equity ratio of 0.23, a current ratio of 1.27 and a quick ratio of 0.78. The Cooper Companies, Inc. has a 1 year low of $58.89 and a 1 year high of $89.83. The stock’s fifty day moving average price is $72.20 and its 200-day moving average price is $71.01.

Cooper Companies (NASDAQ:COO) last released its quarterly earnings data on Thursday, June 4th. The medical device company reported $1.21 EPS for the quarter, beating the consensus estimate of $1.10 by $0.11. Cooper Companies had a return on equity of 10.88% and a net margin of 5.57%.The company had revenue of $1.08 billion for the quarter, compared to analysts’ expectations of $1.05 billion. During the same period last year, the firm posted $0.96 earnings per share. Cooper Companies’s revenue was up 7.9% compared to the same quarter last year. Cooper Companies has set its FY 2026 guidance at 4.580-4.660 EPS. Sell-side analysts expect that The Cooper Companies, Inc. will post 4.63 earnings per share for the current year.

Trending Headlines about Cooper Companies

Here are the key news stories impacting Cooper Companies this week:

• Positive Sentiment: Traders purchased 4,056 call options on COO, roughly 411% above the typical daily volume of 794 contracts. This points to increased speculative bullish interest, although options activity alone does not guarantee a sustained stock advance.
• Neutral Sentiment: The latest short-interest report lists zero shares sold short and a 0.0-day short-interest ratio, but it also describes the change as “NaN” from a prior total of zero. The figures appear inconsistent and provide little useful information about investor positioning. Short Interest Report
• Negative Sentiment: COO’s valuation remains demanding, with a reported P/E ratio near 62. That can make the shares more sensitive to profit-taking or a lack of fresh positive catalysts, even though the company recently exceeded quarterly earnings and revenue expectations and reported year-over-year revenue growth.

Analysts Set New Price Targets

COO has been the topic of a number of analyst reports. Stifel Nicolaus dropped their price target on shares of Cooper Companies from $95.00 to $85.00 and set a “buy” rating on the stock in a research note on Friday, June 5th. BNP Paribas Exane reduced their price objective on shares of Cooper Companies from $95.00 to $92.00 and set an “outperform” rating for the company in a research note on Monday, June 8th. Wall Street Zen raised shares of Cooper Companies from a “hold” rating to a “buy” rating in a report on Sunday, June 21st. Needham & Company LLC dropped their target price on shares of Cooper Companies from $101.00 to $86.00 and set a “buy” rating on the stock in a research note on Friday, June 5th. Finally, Citigroup reiterated a “neutral” rating and set a $80.00 price target (up from $76.00) on shares of Cooper Companies in a report on Thursday, August 13th. One investment analyst has rated the stock with a Strong Buy rating, seven have assigned a Buy rating, six have assigned a Hold rating and three have issued a Sell rating to the stock. According to MarketBeat.com, the company currently has an average rating of “Hold” and an average price target of $81.64.

Cooper Companies Company Profile

Cooper Companies, Inc (NASDAQ: COO) is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women’s health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.